PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Health & Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain.\', \'Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain.\', \'Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.\', \'Musculoskeletal Biomedical Research Unit, NHR Leeds, Leeds, UK.\', \'Patient Engagement, Novartis Pharma AG, Basel, Switzerland.\', \'National Axial Spondyloarthritis Society (NASS), London, UK.\', \'National Rheumatoid Arthritis Society (NRAS), Maidenhead, UK.\', \'Arthritis Action, London, UK.\', \'Rheumatology Department, University Hospital of Grenoble, Grenoble, France.\', \'French League Against Rheumatism (AFLAR), Paris, France.\', \'Cyprus League Against Rheumatism (CYPLAR), Nicosia, Cyprus.\', \'Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal.\', \'Italian National Association of People with Rheumatic and Rare Diseases (APMARR), Lecce, Italy.\', \'Hellenic League Against Rheumatism (ELEANA), Athens, Greece.\', \'Insitute for Musculoskeletal Health (InMusc), Madrid, Spain.\', \'IdiPaz, La Paz University Hospital, Madrid, Spain mvictoria.navarroc@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00154610.1136/rmdopen-2020-001546
?:doi
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 33827969
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all